Platelets stimulate airway smooth muscle cell proliferation through mechanisms involving 5-lipoxygenase and reactive

Ann-Charlotte B Svensson Holm1, Torbjörn Bengtsson, Magnus Grenegård

  • 1Department of Medical and Health Sciences, Division of Drug Research/Pharmacology, Faculty of Health Sciences, Cardiovascular Inflammation Research Centre, Linkoping University, Linkoping, Sweden.

Platelets
|November 4, 2008
PubMed

Insights

Platelets significantly increase airway smooth muscle cell proliferation, a key factor in airway remodeling. This process involves 5-lipoxygenase (5-LOX) and reactive oxygen species (ROS) activation in airway smooth muscle cells.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Inflammation Research

Background:

  • Airway remodeling, characterized by smooth muscle proliferation, is a hallmark of inflammatory airway diseases.
  • Platelet recruitment and activity in the airways are implicated in contributing to airway remodeling.

Purpose of the Study:

  • To investigate the effect of platelets on airway smooth muscle cell (ASMC) proliferation in vitro.
  • To determine the role of 5-lipoxygenase (5-LOX) and reactive oxygen species (ROS) in platelet-induced ASMC proliferation.

Main Methods:

  • ASMCs were co-incubated with platelets, and proliferation was assessed using MTS assay, thymidine incorporation, DNA measurements, and manual counting.
  • Reactive oxygen species (ROS) production was measured using the DCFDA fluorescent probe.
  • The effects of NADPH-oxidase inhibitors (DPI, apocynin), 5-LOX inhibitor (AA-861), and PLA2 inhibitor (ATK) were evaluated. Western blot analysis was used to detect 5-LOX expression.

Main Results:

  • Platelets significantly increased ASMC proliferation in a dose-dependent manner.
  • Platelet co-incubation elevated ROS production, which was attenuated by NADPH-oxidase inhibitors.
  • Inhibition of 5-LOX and PLA2 significantly reduced platelet-induced ASMC proliferation and ROS generation. ASMCs, but not platelets, express 5-LOX.

Conclusions:

  • Platelets possess a significant capacity to induce ASMC proliferation.
  • Platelet-ASMC interaction activates 5-LOX in ASMCs, leading to increased ROS production and subsequent ASMC proliferation.
  • These findings offer insights into mechanisms underlying airway remodeling in inflammatory airway diseases.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation